Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,273.32
(
0.84%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 212835

Friday, 08/18/2017 11:02:12 AM

Friday, August 18, 2017 11:02:12 AM

Post# of 257443
ABBV/ENTA’s Maviret* approved in Canada:

https://finance.yahoo.com/news/abbvies-maviret-approved-health-canada-130300201.html

ENTA does not receive a milestone payment from ABBV for Maviret approval in Canada, but ENTA does get a $15M milestone payment from ABBV for approval in Japan, which is expected in the next two quarters.

*Note spelling, which is the same as the brand name in the EU but differs from the “Mavyret” brand name in the US.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today